Science Creates Ventures is a Bristol-based venture capital firm. Science Creates Ventures EIS Fund 1 offers investment into early-stage deep tech companies. Our focus is on technologies that have the potential to improve healthcare, quality of life, and the environment around us. Science Creates Ventures is supported and backed by successful entrepreneurs behind multiple tech and deep tech exits in the South-West.
The Ventures team understand the innovations they support and know what the ecosystem needs to deliver to build from the discovery upwards. This makes them well equipped to both identify and nurture the winners. Science Creates Ventures is funded by proven entrepreneurs and founders, who span multiple sectors and can support the growth of pioneering companies.
The fund will invest in pre-seed and seed deep tech companies and play an active, strategic role to help the companies commercialise their technologies. Investee companies can also benefit from purpose-built incubators: Unit DX and Unit DY and our partnerships with local academic institutions, entrepreneurs, investors and strategic service providers.
The companies we back will cover many sectors including therapeutics, diagnostics, advanced materials, hardware and software. The Science Creates Ventures investment process focuses on:
The sections of this website which constitute a financial promotion are approved by Kin Capital Partners LLP (“Kin Capital”) for the purposes of section 21 of the Financial Services and Markets Act 2000. Science Creates Ventures (FRN: 933134) is an Appointed Representative of Kin Capital Partners LLP (trading as Kin Fund Services) which is authorised and regulated by the Financial Conduct Authority (FRN: 656789). Science Creates Incubators is a trading style of Unit DX Ltd (Company number 09985771). Unit DX Ltd does not undertake activities subject to FCA Regulation.
Investment are not suitable for all investors. Our investments place your capital at risk and the value of them may go down as well as up. and investors may lose all funds invested. Investments in unquoted early stage/small companies and funds that invest in these smaller companies are high risk and no established market exists for the trading of shares in such companies, making it difficult to sell shares. As such, investors should not invest if likely to require the capital in the near term.
Neither past performance nor forecasts are reliable indicators of future results and should not be relied upon. We recommend you seek independent advice before investing. Tax reliefs are dependent on personal circumstances, and are subject to change in the future. The availability of tax reliefs depends on companies invested in maintaining their qualifying status.